Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer

por Hoff, John, Baldwin, Lauren, Lefringhouse, Jason, Pavlik, Edward, Miller, Rachel, DeSimone, Christopher, Ueland, Frederick, Tucker, Thomas, Kryscio, Richard, van Nagell, J. R.
Publicado 2014

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy

por Xu, B, Lefringhouse, J, Liu, Z, West, D, Baldwin, L A, Ou, C, Chen, L, Napier, D, Chaiswing, L, Brewer, L D, St. Clair, D, Thibault, O, van Nagell, J R, Zhou, B P, Drapkin, R, Huang, J-A, Lu, M L, Ueland, F R, Yang, X H
Publicado 2017